Annual Newsletter 2017

Download a copy here. Newsletter_Autumn_2017.pdf

Latest

The 2020 Ricky Road Run

Take part in the 2020 Ricky Road Run to conquer the 10 mile hilly route through Rickmansworth and Chorleywood, Hertfordshire in support of CPT.
The Glencoe Marathon 2020

Take on the epic 2020 Glencoe Marathon in the stunning Scottish Highlands in support of CPT.
Accelerating Medicines Partnership for Parkinson’s - AMP-PD

The US National Institute of Health (NIH) have recently announced the opening of a vast new data portal for Parkinson's research...
Genetic Manipulators of Alpha Synuclein

A recently published study has identified a gene, DCLK1, as an important regulator of alpha synuclein in Parkinson's.

Accelerating Medicines Partnership for Parkinson’s - AMP-PD

The US National Institute of Health (NIH) have recently announced the opening of a vast new data portal for Parkinson's research...
Genetic Manipulators of Alpha Synuclein

A recently published study has identified a gene, DCLK1, as an important regulator of alpha synuclein in Parkinson's.
Ambroxol: Further Validation for Potential in Parkinson's

A recent study of brain tissue finds certain genetic factors strongly associated with the incidence of Parkinson's and gives further validation to one of our Linked Clinical trials - the Ambroxol trial in people with Parkinson's...
Support a Cure this Christmas: fundraising ideas for the festive season

If you would like to support The Cure Parkinson’s Trust this Christmas we have put together six simple, festive fundraisers that you might like to take part in to help raise awareness and funds for our pioneering Parkinson’s research.
Parkinson's Drug Trial Documentary Wins 'Best Science' Award

'The Parkinson’s Drug Trial: A Miracle Cure?' has won a Grierson Award for Best Science Documentary. The series aired in early 2019 and followed late CPT Co-founder Tom Isaacs and 8 other people through a pioneering drug delivery procedure...
Dr Heather Mortiboys and Dr Kevin McFarthing join CPT's Research Committee

The Cure Parkinson's Trust is pleased to announce two new additions to its Research Committee: Dr Heather Mortiboys and Dr Kevin McFarthing.
Autumn Research Update Meeting 2019

Presentations from our Autumn Research Patient Update Meeting are now available to view.
Martin Wishart's Atlantic Sail for CPT

To mark the 20th anniversary of running his Edinburgh restaurant, Scottish Michelin Star Chef Martin Wishart will be taking on the incredible challenge of sailing 3,500 miles across the Atlantic in a bid to raise awareness and funds for The Cure Parkinson’s Trust.
A New Enzyme to Inhibit LRRK2

Researchers in Dundee and Stanford (USA) have identified a novel method of reducing the hyperactivity of the gene mutation in LRRK2, a major cause of familial and sporadic cases of Parkinson's...
The 2020 Cure Parkinson’s Cup Tournament

The very first Cure Parkinson’s Cup is set to take place on 19 April 2020. Players with Parkinson’s of any ability, age or gender are invited to enter this exciting new tournament which is raising funds to help pay for potentially life-changing research.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

Our Annual Review 2019

Our Annual Review 2019 - your online publication here... Read more